Meyer, Everett
Maahs, David M.
Article History
First Online: 9 February 2018
Competing interests
: E.H.M. is funded by the NIH (including 1P30DK116074), JDRF Career Development Award and the Helmsley Charitable Trust. He has no conflicts regarding this topic, but is an adviser and equity holder in GigaGen and Triursus Therapeutics. He also is on an advisory board for Incyte. D.M.M. is funded by the NIH (including 1P30DK116074), JDRF, NSF and the Helmsley Charitable Trust. He has no conflicts regarding this topic, but is on an advisory board for Insulet, has consulted for Abbott Diabetes Care and the Helmsley Charitable Trust, and his institution has received research support or materials from Medtronic, Dexcom, Insulet, Bigfoot Biomedical, Type Zero and Roche.